Phcog.Net logo

BROWSE ALL JOURNALS

    SEE ALL 6 JOURNALS
    Article

    Statin induced diabetes and its clinical implications

    Umme Aiman1, Ahmad Najmi2, Rahat Ali Khan1 Corresponding author

    1. 1Departments of Pharmacology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.
    2. 2Index Medical College, Indore, Madhya Pradesh, India.

    CORRESPONDENCE

    Umme Aiman

    Departments of Pharmacology, Jawaharlal Nehru Medical College, Aligarh Muslim University, Aligarh, Uttar Pradesh, India.

    Received: 30-12-2013; Revised: 01-02-2014; Accepted: 16-02-2014.

    Volume 5, Issue 3 · pp. 181–185 · PUBLISHED 2014 · DOI: 10.4103/0976-500X.136097

    View on J Pharmacol. Pharmacother. original site ↗

    ABSTRACT

    Statins are one of the most commonly used drugs in the world based on their potential to prevent adverse cardiovascular events. These cholesterol‑lowering drugs received a US Food and Drug Administration warning, in February 2012, regarding increased risk of incident diabetes and impaired glycemic control in patients who already have diabetes. The possible association of diabetes with statin therapy has started a wave of discussion in the medical community. A number of meta‑analyses conducted in recent years have demonstrated that the association is real although causality has not been proved yet. Individual statins differ with respect to their diabetogenic property; women and elderly persons appear to be at increased risk. Various aspects of statin’s adverse effect on glycemic control remain to be explored. As further research in this area continues, physicians might still take some precautions to make risk benefit ratio more favorable for the patients.

    KEYWORDS

    Open in new tab

    REFERENCES

    As published

    Showing references and in-text citations exactly as published.

      Cite this article

      SELECT FORMAT

      Aiman, U., Najmi, A., & Khan, R. A. (2014). Statin induced diabetes and its clinical implications. Journal of Pharmacology and Pharmacotherapeutics, 5(3), 181–185. https://doi.org/10.4103/0976-500X.136097